Chief of Oncology
John M. Maris, MD
The Director of the CCCR and Chief of the Division of Oncology. He is looking for genetic abnormalities that may also occur early in the development of the more common, non-inherited form of the disease. In addition, he has shown the importance of genetic alteration in the tumor cells for predicting prognosis.